SCHEMBL8068683

SCHEMBL8068683

CS(=O)(=O)c1cc(C(=O)NC(=N)N)ccc1Oc1ccc(C(=O)NC(=N)N)cc1

nearest known ligand 0.46

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.41
HPGD P15428 1/20 0.41
TSHR P16473 1/20 0.41
HTT P42858 1/20 0.41
F10 P00742 1/20 0.39
PLAU P00749 1/20 0.39
MRGPRX1 Q96LB2 3/20 0.38
MMP13 P45452 1/20 0.38
GCK P35557 1/20 0.36
KDM4E B2RXH2 1/20 0.36
MAPT P10636 1/20 0.36
LMNA P02545 1/20 0.36
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
FTO Q9C0B1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8059609 0.99 SMN1; SMN2 (0.40) SMN1; SMN2HPGDTSHRHTTF10
SCHEMBL8379266 0.94 HPGD (0.41) SMN1; SMN2HPGDTSHRHTTF10
SCHEMBL8743801 0.94 PARP10 (0.40) SMN1; SMN2HPGDTSHRHTTF10
Hydrochloric Acid SCHEMBL8374986 0.93 HPGD (0.40) SMN1; SMN2HPGDTSHRHTTF10
Hydrochloric Acid SCHEMBL8743791 0.93 PARP10 (0.40) F10PLAUMRGPRX1
SCHEMBL8743804 0.93 KMT2A (0.41) SMN1; SMN2HTTF10
SCHEMBL8743793 0.93 MRGPRX1 (0.44) SMN1; SMN2HPGDF10MRGPRX1LMNA
SCHEMBL8499411 0.93 GCK (0.42) F10PLAUGCK
SCHEMBL8446348 0.92 CA2 (0.43) TSHRHTTF10MRGPRX1KDM4E
Hydrochloric Acid SCHEMBL8743783 0.92 MRGPRX1 (0.44) SMN1; SMN2HPGDF10MRGPRX1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6057322-A USEFUL IN TREATMENT OF CARDIOVASCULAR DISEASES HOECHST AKTIENGESELLSCHAFT (DE) 2000-05-02 US disclosed
EP-0723956-B1 Basically substituted benzoylguanidines, process for their preparation, their use as medicaments or diagnostics as well as medicaments containing them HOECHST AG (DE) 1999-10-13 EP disclosed
EP-0723956-A1 Basically substituted benzoylguanidines, process for their preparation, their use as medicaments or diagnostics as well as medicaments containing them HOECHST AKTIENGESELLSCHAFT (DE) 1996-07-31 EP disclosed